U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

National Guideline Centre (UK). Suspected neurological conditions: recognition and referral. London: National Institute for Health and Care Excellence (NICE); 2019 May. (NICE Guideline, No. 127.)

Cover of Suspected neurological conditions

Suspected neurological conditions: recognition and referral.

Show details

Appendix KForest plots

K.1. Part 1: Adults aged over 16 – signs, symptoms and investigative tests

K.1.1. Dizziness and vertigo including the HINTS test in adults

K.1.1.1. Dizziness and vertigo

Figure 12. Serious neurological diagnoses versus other diagnoses – Risk factor: focal examination abnormality.

Figure 12Serious neurological diagnoses versus other diagnoses – Risk factor: focal examination abnormality

Figure 13. Serious neurological diagnoses versus other diagnoses – Risk factor: imbalance.

Figure 13Serious neurological diagnoses versus other diagnoses – Risk factor: imbalance

Figure 14. Serious neurological diagnoses versus other diagnoses – Risk factor: isolated dizziness.

Figure 14Serious neurological diagnoses versus other diagnoses – Risk factor: isolated dizziness

K.1.1.2. HINTS test

K.1.1.2.1. Coupled sensitivity and specificity forest plots
Figure 15. HINTS test Coupled sensitivity and specificity.

Figure 15HINTS test Coupled sensitivity and specificity

K.1.1.2.2. Pooled estimate of sensitivity and specificity
Figure 16. Graph of pooled estimate of sensitivity and specificity with 95% confidence intervals.

Figure 16Graph of pooled estimate of sensitivity and specificity with 95% confidence intervals

K.1.2. Facial pain, atraumatic

No relevant clinical studies were identified.

K.1.3. Memory failure in adults (Memory tests)

No relevant clinical studies were identified.

K.1.4. Sensory symptoms such as tingling or numbness in adults

No relevant clinical studies were identified.

K.1.5. Tremor in adults

No relevant clinical studies were identified.

K.2. Part 2: Children aged under 16 – signs, symptoms and investigative tests

K.2.1. Blackouts and other paroxysmal events

No relevant clinical studies were identified.

K.2.2. Headache

No relevant clinical studies were identified.

K.2.3. Head shape and size abnormalities

No relevant clinical studies were identified.

K.2.4. Motor developmental delay and unsteadiness (creatine kinase tests)

No relevant clinical studies were identified.

K.2.5. Sensory symptoms such as tingling or numbness in children

No relevant clinical studies were identified.

Copyright © NICE May 2019.
Bookshelf ID: NBK542035

Views

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...